Evolent Health completed the acquisition of Magellan Specialty Health from Centene for $800m.

Evolent Health, a proven clinical and administrative solutions provider, completed the acquisition of Magellan Specialty Health, a specialty benefit management organization, from Centene, a healthcare enterprise, for $800m. "Today's announcement represents another step forward in Evolent's journey to become a national leader in value-based specialty care, and we believe it will also improve our financial profile, customer diversification and scale. I am also excited to significantly expand our strategic partnership with Centene, and I look forward to the opportunity to further grow our relationship in the time ahead," Seth Blackley, Evolent CEO.